Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta
Open Access
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 129, 110506
Abstract
No abstract availableKeywords
Funding Information
- Charles University (PRIMUS/20/MED/010, SVV 260 549)
- Grant Agency of the Charles University GAUK (616216/C/2016)
- EFSA-CDN (CZ.02.1.01/0.0/0.0/16_019/0000841)
- National Research, Development and Innovation Office (FK 128751)
- Hungarian Academy of Sciences
This publication has 76 references indexed in Scilit:
- Regulation of Nutrient Transport across the PlacentaJournal of Pregnancy, 2012
- OATPs, OATs and OCTs: the organic anion and cation transporters of theSLCOandSLC22Agene superfamiliesBritish Journal of Pharmacology, 2012
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid SolubilityThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Drug transporters in the human blood‐placental barrierBritish Journal of Pharmacology, 2009
- Distribution of Saquinavir, Methadone, and Buprenorphine in Maternal Brain, Placenta, and Fetus During Two Different Gestational Stages of Pregnancy in MiceJournal of Pharmaceutical Sciences, 2009
- Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potentialDifferentiation, 2008
- Maraviroc:in vitroassessment of drug–drug interaction potentialBritish Journal of Clinical Pharmacology, 2008
- Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteersBritish Journal of Clinical Pharmacology, 2008
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicology and Applied Pharmacology, 2005